Insiders Traws Pharma, Inc.

Equities

TRAW

US68232V8019

Delayed Nasdaq Other stock markets 15:46:26 15/05/2024 BST			5-day change	1st Jan Change
0.6455 ^USD	-0.71%		-2.83%	-15.24%

05-07	Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy	CI
04-04	North American Morning Briefing : Focus Turns to -2-	DJ

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Traws Pharma, Inc. Announces Chief Executive Office Changes	04-04	CI
Traws Pharma, Inc. Announces Board Changes	04-04	CI
Onconova Therapeutics, Inc and Trawsfynydd Therapeutics, Inc. Announce Management Appointments for the Combined Company Traws Pharma, Inc	04-02	CI
Onconova Therapeutics, Inc. Appoints Victor Moyo as Chief Medical Officer	24/10/23	CI
Onconova Therapeutics Chief Medical Officer Mark Gelder Dies Unexpectedly	06/04/23	MT
Onconova Therapeutics, Inc. Announces Board Appointments	19/12/22	CI
Onconova Therapeutics Gives CFO Mark Guerin Additional Role of Chief Operating Officer	13/06/22	MT
Onconova Therapeutics, Inc. Announces Executive Changes	13/06/22	CI
Onconova Therapeutics, Inc. Appoints Adar Makovski Silverstein as Director, Corporate Development	17/03/22	CI
Onconova Therapeutics, Inc. Appoints Adar Makovski Silverstein as Director, Corporate Development	13/12/21	CI
Onconova Therapeutics, Inc. Announces the Appointment of Mark Gelder as Chief Medical Officer, Effective June 14, 2021	01/06/21	CI
Onconova Therapeutics, Inc. Announces Resignation of Richard C. Woodman, MD, Senior Vice President Chief Medical Officer	15/01/21	CI
Manoj Maniar, Ph.D., Senior Vice President, Product Development departs from Onconova Therapeutics, Inc	18/12/20	CI
Onconova Therapeutics, Inc. Announces Board Changes	31/08/20	CI
Onconova Therapeutics Strengthens Board of Directors with Nomination of Life Sciences Industry Veteran	27/04/20	GL
Onconova Therapeutics Appoints Dr. Steven M. Fruchtman as Chief Executive Officer and a Member of the Board of Directors	15/01/19	CI
Onconova Therapeutics, Inc. Appoints Abraham “Avi” Oler as Vice President, Corporate Development and General Counsel	10/12/18	CI
Onconova Therapeutics, Inc. Appoints Richard Woodman as Chief Medical Officer and Senior Vice President of Research & Development	07/11/18	CI
Onconova Therapeutics, Inc. Announces Promotion of Steven M. Fruchtman to President	21/06/18	CI
Onconova Therapeutics, Inc. Appoints Jack E. Stover to its Board of Directors	23/05/16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Traws Pharma, Inc.

Equities

TRAW

US68232V8019

Insiders

Filters